Intrua Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Intrua Financial's ARKG Position: Q1 2026 in Review
Intrua Financial sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 14,290 shares — an estimated $414K sold.
Intrua Financial first reported a position in ARKG in Q2 2020 and held it in 20 quarters. The position peaked at $3.44M in Q1 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Intrua Financial reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
- Intrua Financial sold 14,290 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $414K.
- Intrua Financial first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 20 quarters.
- Intrua Financial's ARK Genomic Revolution ETF position peaked at $3.44M in Q1 2021.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Intrua Financial's 13F filing for Q1 2026, filed 23 Apr 2026.